Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In this retrospective analysis, all DM patients with hypoalbuminemia (albumin < 3.5 g/dL) admitted to internal medicine "E" at Wolfson Medical Center between 1 June 2016 and 30 April 2017 were included.
|
31398808 |
2019 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hypoalbuminemia in early onset dentatorubral-pallidoluysian atrophy due to leakage of albumin in multiple organs.
|
23263592 |
2013 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Although the biopsy population included primary and secondary glomerular disease patients, all 17 RVT patients had severe nephrotic syndrome and profound hypoalbuminemia with mean (SD) of albumin: 1.5 g/dL (0.66).
|
27796697 |
2017 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
While an association between hypoalbuminemia and increased risk of acute kidney injury (AKI) is well-established, the risk of AKI development and its severity among patients with elevated serum albumin is unclear.
|
29927987 |
2018 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hypoalbuminemia was present in 41 (25.2%) patients and serum albumin ≤3.3 g/dL represented the lowest quartile of serum albumin.
|
29604093 |
2018 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
PSMVT was confirmed by contrast-enhanced CT. Multivariate stepwise logistic regression analyses showed that Balthazar's CT severity index (CTSI) scores [odds ratio (OR): 2.742; 95% confidence interval (CI): 1.664-4.519; <i>P</i> = 0.000], hypoalbuminemia (serum albumin level < 25 g/L) (OR: 32.573; 95%CI: 2.711-391.353; <i>P</i> = 0.006) and gastrointestinal wall thickening (OR: 4.367, 95%CI: 1.218-15.658; <i>P</i> = 0.024) were independent risk factors for PSMVT developed in patients with SAP.
|
30254409 |
2018 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We present a case of a 15-month-old female infant with type I biliary atresia with jaundice (total serum bilirubin, 22.2 mg/dL), hypoalbuminemia (serum albumin level, 2.58 g/dL), coagulopathy (prothrombin time > 20 s compared with that of a normal control), ascites, splenomegaly, portal hypertension (portal vein velocity, 3.9-5.6 cm/sec of hepatopetal flow), and repeated bleeding of the varices after receiving three doses of intravascularly administered Histoacryl 1 ampoule mixed with Lipiodol UF 8 mL in the EV.
|
30819091 |
2019 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Five thousand six hundred seventy-three patients with albumin available were identified, and 29.6% had hypoalbuminemia.
|
30720559 |
2019 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Nephrotic syndrome without hypoalbuminemia (23.6%) was the most prevalent reason for albumin misuse and internal ward was the most consuming unit.
|
28979337 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The SUV<sub>mean</sub> of the mediastinal blood uptake in patients with hypoalbuminemia and normal serum albumin were 1.6 ± 0.2 and 1.7 ± 0.3, respectively (p = 0.053).
|
31201673 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The 2005-2012 National Surgical Quality Improvement Program was analyzed to determine associated complications, mortality, length of stay (LOS), and readmissions for patients with hypoalbuminemia (serum albumin <3.5 g/dL and <2.8 g/dL) undergoing infrainguinal lower extremity bypass for critical limb ischemia.
|
28242402 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The effect of having hypoalbuminemia (defined as albumin ≤3.5 g/dL) on selected outcomes was examined using fully adjusted multivariable models.
|
30481611 |
2018 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Multivariate logistic regression analyses showed that HD duration, the normalized protein catabolic rate (nPCR), hypoalbuminemia (albumin < 4 g/dl), and the mean previous 12-month environmental PM2.5 were positively associated with CTS; HD duration, nPCR, hypoalbuminemia (albumin < 4 g/dl), and the mean previous 24-month environmental PM2.5 were positively associated with CTS; HD duration, hypoalbuminemia (albumin < 4 g/dl), and previous 12-month PM2.5 excess days were positively associated with CTS; and HD duration, nPCR, hypoalbuminemia (albumin < 4 g/dl), and previous 24-month PM2.5 excess days were positively associated with CTS.
|
29161700 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Albumin is often prescribed in infants with hypoalbuminemia, hyperbilirubinemia, and protein-losing conditions.
|
28739260 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The incidence of organ failure was 3.5%, 10.6%, and 41.6% in patients with normal albumin and mild and severe hypoalbuminaemia, respectively.
|
29147647 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hypoalbuminemia was defined as serum albumin ≤ 2.9 g/dL.
|
31447891 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
On logistic regression analysis, age, hematuria, severe hypoalbuminemia (serum albumin <1.0 g/dL) and severe bacterial infection were not independent factors, but female sex {hazard ratio [HR] 1.5 [95% confidence interval (CI) 1.1-1.7]} and hypertension [HR 4.0 (95% CI 2.6-6.0)] were significantly related to AKI.
|
31550360 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
In theory, any additional albumin loss should be minimized because it may contribute to hypoalbuminemia and adversely affect the patient's prognosis.
|
29106652 |
2018 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Because preimplant hypoalbuminemia is a known risk factor for adverse outcomes, we hypothesized that change in albumin may be a prognostic indicator in patients with continuous-flow left ventricular assist devices (cfLVADs).
|
28947307 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Though median serum cholesterol values did not differ significantly between survivors and non-survivors, cats with concurrent hypoalbuminemia were at higher risk (odds ratio 15.6, 95% confidence interval 5.2-46.6; <i>P</i> <0.0001) of not surviving to discharge than cats with normal serum albumin concentrations.
|
31710272 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
On multivariate regression, severity of hypoalbuminemia was associated with increasing waitlist mortality, even after correcting for model for end stage liver disease-sodium and HCC [albumin, 2.5 to 3.4 g/dL: hazard ratio (HR), 1.81; 95% confidence interval (CI), 1.62-2.01; P<0.001; <2.5 g/dL: HR, 2.46; 95% CI, 2.20-2.76; P<0.001].
|
29356783 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
After 4 years of follow-up, Kaplan-Meier analysis showed that survival in hypoalbuminemia patients was significantly shorter than in patients with normal SA (p = 0.0393).
|
27817055 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Compared to 30-day mortality with normal albumin on admission (2%), mortality was higher with mild (9%) and marked hypoalbuminemia (22%) and lower with hyperalbuminemia (0.4%).
|
31760678 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
There is no evidence that shifts of albumin to the extravascular space or that dilution of the plasma by volume expansion plays any role in causing hypoalbuminemia in ESRD patients.
|
9848794 |
1998 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
After adjusting for confounding factors, hypoalbuminemia was an independent predictor of in-hospital mortality in patients with either type A (HR, 2.492; 95% confidence interval [CI], 1.247-4.979; P = .010) or type B (HR, 8.729; 95% CI, 1.825-41.736; P = .007).SA is independently associated with increased in-hospital mortality in both type A and B AAD.
|
30732220 |
2019 |